Call Me Free
Home ›› Products ›› API ›› Anidulafungin API
Previous Product Next Product
Anidulafungin API

Anidulafungin API

Anidulafungin API, also known as Eraxis, is a potent antifungal medication developed by Pfizer and FDA-approved on February 21, 2006. Previously identified as LY303366, it offers promising efficacy against fungal infections. Anidulafungin shares a comparable safety profile with caspofungin, showcasing its potential as a reliable treatment option. As an active pharmaceutical ingredient, Anidulafungin API plays a crucial role in the formulation of antifungal medications, ensuring effective management of fungal infections. With Pfizer's reputation for quality pharmaceuticals, Anidulafungin API stands as a testament to innovation and commitment to improving patient outcomes in the fight against fungal diseases.
Inquiry Now

Manufacturing Unit-I

Block/Survey No. 497, Mauhuvej, nr. Fairdeal Textile Park, Kosamba, Gujarat 394125, India